Literature DB >> 17131163

Hybridization analysis of D4Z4 repeat arrays linked to FSHD.

Melanie Ehrlich1, Kesmic Jackson, Koji Tsumagari, Pilar Camaño, Richard J F L Lemmers.   

Abstract

Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant disease involving shortening of D4Z4, an array of tandem 3.3-kb repeat units on chromosome 4. These arrays are in subtelomeric regions of 4q and 10q and have 1-100 units. FSHD is associated with an array of 1-10 units at 4q35. Unambiguous clinical diagnosis of FSHD depends on determining the array length at 4q35, usually with the array-adjacent p13E-11 probe after pulsed-field or linear gel electrophoresis. Complicating factors for molecular diagnosis of FSHD are the phenotypically neutral 10q D4Z4 arrays, cross-hybridizing sequences elsewhere in the genome, deletions including the genomic p13E-11 sequence and part of D4Z4, translocations between 4q and 10q D4Z4 arrays, and the extremely high G + C content of D4Z4 arrays (73%). In this study, we optimized conditions for molecular diagnosis of FSHD with a 1-kb D4Z4 subfragment probe after hybridization with p13E-11. We demonstrate that these hybridization conditions allow the identification of FSHD alleles with deletions of the genomic p13E-11 sequence and aid in determination of the nonpathogenic D4Z4 arrays at 10q. Furthermore, we show that the D4Z4-like sequences present elsewhere in the genome are not tandemly arranged, like those at 4q35 and 10q26.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17131163      PMCID: PMC1828046          DOI: 10.1007/s00412-006-0080-6

Source DB:  PubMed          Journal:  Chromosoma        ISSN: 0009-5915            Impact factor:   4.316


  32 in total

1.  Whole-genome methylation scan in ICF syndrome: hypomethylation of non-satellite DNA repeats D4Z4 and NBL2.

Authors:  T Kondo; M P Bobek; R Kuick; B Lamb; X Zhu; A Narayan; D Bourc'his; E Viegas-Péquignot; M Ehrlich; S M Hanash
Journal:  Hum Mol Genet       Date:  2000-03-01       Impact factor: 6.150

2.  Methylation of the FSHD syndrome-linked subtelomeric repeat in normal and FSHD cell cultures and tissues.

Authors:  F Tsien; B Sun; N E Hopkins; V Vedanarayanan; D Figlewicz; S Winokur; M Ehrlich
Journal:  Mol Genet Metab       Date:  2001-11       Impact factor: 4.797

3.  Genomic analysis of human chromosome 10q and 4q telomeres suggests a common origin.

Authors:  Michel van Geel; Morag C Dickson; Amy F Beck; Daniel J Bolland; Rune R Frants; Silvère M van der Maarel; Pieter J de Jong; Jane E Hewitt
Journal:  Genomics       Date:  2002-02       Impact factor: 5.736

4.  Complete allele information in the diagnosis of facioscapulohumeral muscular dystrophy by triple DNA analysis.

Authors:  P de Kievit; M van Geel; M J van der Wielen; E Bakker; G W Padberg; R R Frants; S M van der Maarel
Journal:  Ann Neurol       Date:  2001-12       Impact factor: 10.422

5.  Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere.

Authors:  Richard J L F Lemmers; Peggy de Kievit; Lodewijk Sandkuijl; George W Padberg; Gert-Jan B van Ommen; Rune R Frants; Silvère M van der Maarel
Journal:  Nat Genet       Date:  2002-09-23       Impact factor: 38.330

6.  D4F104S1 deletion in facioscapulohumeral muscular dystrophy: phenotype, size, and detection.

Authors:  R J L F Lemmers; M Osborn; T Haaf; M Rogers; R R Frants; G W Padberg; D N Cooper; S M van der Maarel; M Upadhyaya
Journal:  Neurology       Date:  2003-07-22       Impact factor: 9.910

7.  Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q.

Authors:  Guanchao Jiang; Fan Yang; Petra G M van Overveld; Vettaikorumakankav Vedanarayanan; Silvere van der Maarel; Melanie Ehrlich
Journal:  Hum Mol Genet       Date:  2003-09-23       Impact factor: 6.150

8.  Facioscapulohumeral muscular dystrophy. Phenotype-genotype correlation in patients with borderline D4Z4 repeat numbers.

Authors:  Miriam Butz; Manuela C Koch; Wolfgang Müller-Felber; Richards J L F Lemmers; Silvère M van der Maarel; Herbert Schreiber
Journal:  J Neurol       Date:  2003-08       Impact factor: 4.849

9.  Chromosome 4q;10q translocations; comparison with different ethnic populations and FSHD patients.

Authors:  Tsuyoshi Matsumura; Kanako Goto; Gaku Yamanaka; Je Hyeon Lee; Cheng Zhang; Yukiko K Hayashi; Kiichi Arahata
Journal:  BMC Neurol       Date:  2002-08-20       Impact factor: 2.474

10.  Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle.

Authors:  Davide Gabellini; Michael R Green; Rossella Tupler
Journal:  Cell       Date:  2002-08-09       Impact factor: 41.582

View more
  11 in total

1.  New multiplex PCR-based protocol allowing indirect diagnosis of FSHD on single cells: can PGD be offered despite high risk of recombination?

Authors:  Mouna Barat-Houari; Karine Nguyen; Rafaëlle Bernard; Céline Fernandez; Catherine Vovan; Corinne Bareil; Philippe Khau Van Kien; Delphine Thorel; Sylvie Tuffery-Giraud; Francis Vasseur; Shahram Attarian; Jean Pouget; Anne Girardet; Nicolas Lévy; Mireille Claustres
Journal:  Eur J Hum Genet       Date:  2009-11-25       Impact factor: 4.246

2.  Worldwide population analysis of the 4q and 10q subtelomeres identifies only four discrete interchromosomal sequence transfers in human evolution.

Authors:  Richard J L F Lemmers; Patrick J van der Vliet; Kristiaan J van der Gaag; Sofia Zuniga; Rune R Frants; Peter de Knijff; Silvère M van der Maarel
Journal:  Am J Hum Genet       Date:  2010-03-04       Impact factor: 11.025

3.  Cis D4Z4 repeat duplications associated with facioscapulohumeral muscular dystrophy type 2.

Authors:  Richard J L F Lemmers; Patrick J van der Vliet; Jeroen P Vreijling; Don Henderson; Nienke van der Stoep; Nicol Voermans; Baziel van Engelen; Frank Baas; Sabrina Sacconi; Rabi Tawil; Silvère M van der Maarel
Journal:  Hum Mol Genet       Date:  2018-10-15       Impact factor: 6.150

Review 4.  The muscular dystrophies: distinct pathogenic mechanisms invite novel therapeutic approaches.

Authors:  Zarife Sahenk; Jerry R Mendell
Journal:  Curr Rheumatol Rep       Date:  2011-06       Impact factor: 4.592

5.  FSH dystrophy and a subtelomeric 4q haplotype: a new assay and associations with disease.

Authors:  K Tsumagari; D Chen; J R Hackman; A D Bossler; M Ehrlich
Journal:  J Med Genet       Date:  2010-08-15       Impact factor: 6.318

6.  High-resolution breakpoint junction mapping of proximally extended D4Z4 deletions in FSHD1 reveals evidence for a founder effect.

Authors:  Richard J L F Lemmers; Patrick J van der Vliet; David San Leon Granado; Nienke van der Stoep; Henk Buermans; Robin van Schendel; Joost Schimmel; Marianne de Visser; Rudy van Coster; Marc Jeanpierre; Pascal Laforet; Meena Upadhyaya; Baziel van Engelen; Sabrina Sacconi; Rabi Tawil; Nicol C Voermans; Mark Rogers; Silvère M van der Maarel
Journal:  Hum Mol Genet       Date:  2022-03-03       Impact factor: 5.121

7.  Validation of Optical Genome Mapping for the Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy.

Authors:  Aaron A Stence; Jon G Thomason; Jonathan A Pruessner; Ramakrishna R Sompallae; Anthony N Snow; Deqin Ma; Steven A Moore; Aaron D Bossler
Journal:  J Mol Diagn       Date:  2021-08-09       Impact factor: 5.568

8.  Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy.

Authors:  Takako I Jones; Oliver D King; Charis L Himeda; Sachiko Homma; Jennifer C J Chen; Mary Lou Beermann; Chi Yan; Charles P Emerson; Jeffrey B Miller; Kathryn R Wagner; Peter L Jones
Journal:  Clin Epigenetics       Date:  2015-03-29       Impact factor: 6.551

9.  Analysis of the largest tandemly repeated DNA families in the human genome.

Authors:  Peter E Warburton; Dan Hasson; Flavia Guillem; Chloe Lescale; Xiaoping Jin; Gyorgy Abrusan
Journal:  BMC Genomics       Date:  2008-11-07       Impact factor: 3.969

10.  Epigenetics of a tandem DNA repeat: chromatin DNaseI sensitivity and opposite methylation changes in cancers.

Authors:  Koji Tsumagari; Lixin Qi; Kesmic Jackson; Chunbo Shao; Michelle Lacey; Janet Sowden; Rabi Tawil; Vettaikorumakankav Vedanarayanan; Melanie Ehrlich
Journal:  Nucleic Acids Res       Date:  2008-02-16       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.